more_reports

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

MindBio Therapeutics Positions Voice AI Kiosks for Growth in Workplace Safety Markets

  ()
MindBio Therapeutics advances prototype Edge AI kiosks for non-invasive intoxication and fatigue detection, targeting high-growth opportunities in mining, aviation, and construction sectors amid expanding biotech and AI markets.

MindBio Therapeutics Positions Voice AI Technology for Growth in Safety-Critical Sectors

  ()
Explore how MindBio Therapeutics is advancing voice-based AI detection for intoxication across mining, aviation, and other industries, backed by strong market trends and analyst targets.

MindBio Therapeutics Advances AI Voice Tech for Workplace Safety in Growing Biotech and AI Detector Markets

  ()
MindBio Therapeutics delivers first prototype Edge AI kiosks for non-invasive intoxication and fatigue detection, positioning the company in high-growth sectors including mining, aviation, and construction, while analysts highlight significant upside potential.

Biotech Firm Launches Massive AI Safety Solution for Zero-Tolerance Industries

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) delivers first Edge AI intoxication detection kiosk prototypes for mining, aviation, and construction safety screening.

Grey Matters Health Positions for Growth in Expanding Alzheimer's Diagnostics Market

  ()
Grey Matters Health advances its Alzheimer's neuroimaging strategy with fresh financing and plans for the first U.S. brain-specific PET clinic, capitalizing on rising demand for early detection tools.

Biotech Firm Deploys Revolutionary Intox AI, Unlocking Billion-Dollar Industrial Safety Opportunity

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) launches Intox AI, detecting intoxication via voice, targeting mining and aviation in a US$2.06B market.

Alzheimer's Diagnostic Clinic Initiative Moves Forward After Financing Close

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) closed the first CA$500,000 tranche of a financing that the company said will support its Alzheimer's disease program and planned U.S. brain-specific neuroimaging clinic.

Cancer Drug Developer Shifts 70% of Spending to Research as AI Pipeline Progresses

  ()
Rakovina Therapeutics (TSX.V: RKV) reported lower net losses, reduced administrative spending, debt restructuring, financing activity, and progress across its AI-driven oncology pipeline in Q1 2026.

New Alzheimer's Imaging Push Expands as Financing Terms Get Investor-Friendly

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) amended warrant terms tied to its CA$1 million private placement as it advances plans for a U.S. brain-specific neuroimaging clinic focused on Alzheimer's diagnostics.

200 Brain PET Scans, 162 Alzheimer's Drugs: A Diagnostic Push Takes Shape

  ()
Grey Matters Health Inc. (GREY:CSE; AGW0:FRA; AGNPF:OTCQB) signed an LOI tied to a minimum of 200 brain PET scans for an Alzheimer's clinical trial while expanding its NovaScan neuroimaging strategy.

Cleantech Co. Wins PFAS Deal, Engineering Pact, Ships Clyra

Research Report
  ()
BioLargo (BLGO:OTCQX) shipped Clyra's first stocking order, signed Aquatech PFAS MOU, and won a US$1.2M engineering contract for a minerals processing facility, according to an Oak Ridge Financial research note

Biotech Co. Unveils Scalable AI Voice Biomarker Platform

  ()
MindBio Therapeutics Corp.'s (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) CEO says proprietary AI voice analytics could transform impairment screening across zero-tolerance industries.

Biotech Co. Advances AI Detection Breakthrough for Intoxication Safety

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) enhances AI speech analysis tech with cross-language capability, paving the way for major accident-prevention potential.

CleanTech Company Advances Global PFAS Water Treatment Partnership with Aquatech

  ()
Cleantech and life sciences innovator BioLargo Inc. (BLGO:OTCQX) notches multiple wins this week for the distribution of its products worldwide.

Biotech Co. Finds Massive Physiological Screening Breakthrough

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) files patents for novel voice-biomarker intoxication detection, targeting applications in mining and aviation.

New York Healthcare Technology Co. Discovers Scalable Behavioral Health Breakthrough

  ()
DarioHealth Corp.'s (DRIO:NASDAQ) study showed measurable workplace productivity and cognitive function improvements in 1,254 users within weeks, boosting growth potential.

Biotech Firm Advances Voice-Based Intoxication Tech Aiming to Revolutionize Medical Diagnostics

  ()
MindBio Therapeutics Corp.'s (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) AI voice model analyzes 140+ biomarkers, targeting non-invasive impairment screening.

Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) appoints Chilean policy leader Felipe Leyton for the mining rollout of its AI impairment detection tech.

The World's First AI Voice Detection For Drugs & Alcohol With Charts That Beckon Investors To Buy

Contributed Technical Analyst Opinion
  ()
Technical Analyst Stewart Thomson explains why he thinks MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) is a Speculative Buy.

First US Brain-Only PET Clinic Targets Alzheimer's Detection as Diagnostic Demand Expands

  ()
Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is opening its inaugural brain PET clinic in Florida with a five-year lease and renewal option.

America's First Brain-Dedicated PET Scanning Clinics: A Turnaround Play for Chart-Savvy Investors?

Contributed Technical Analyst Opinion
  ()
Technical Analyst Stewart Thomson explains why he thinks Algernon Health (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) is a Strong Speculative Buy.

Biotech Company Accelerates AI Detection Breakthrough Globally

  ()
MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) advanced AI-powered screening kiosks, targeting safer operations across industrial sectors.

An AI-Powered Doctor & Patient Platform: Why This North American Provider is Gaining Market Momentum

Contributed Technical Analyst Opinion
  ()
Technical Analyst Stewart Thomson explains why he likes Rocket Doctor AI Inc. (AIDR:CSE; TREIF:OTC; 939:FRA).

Biotech Expands Financing to CA$2M as AI-Driven Cancer Drug Programs Advance

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) increased its previously announced financing to approximately US$2.0 million through a convertible debenture and private placement. The company stated the proceeds will support working capital needs and ongoing corporate and strategic initiatives.

Showing Results: 1 to 25 of 28 Next